Fundraising Fox
/Companies
Sign in

LYNK Pharmaceuticals

Hangzhou, CN · 3 known investors

Find your way into LYNK Pharmaceuticals

Each arrow is one introduction. Sign up to fill in the first one.

109 people can intro you to Michael

Ask Saundra Pelletier to introduce you to Michael Vazquez

You →Saundra · together at G.D. Searle Company →Michael

72 people can intro you to Jun

Ask Jamie Chen to introduce you to Jun Wang

You →Jamie · together at The University of Texas Southwestern Medical Center at Dallas →Jun

Sign up to find every way you can get introduced to LYNK Pharmaceuticals

  • Your email: who you already know at LYNK Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the LYNK Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Lynk Pharma develops pharmaceutical products for rheumatoid arthritis and ankylosing spondylitis, with selective licensing arrangements for regional commercialization.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Founders & leadership

Z(
Zhao-Kui (ZK) WanFounder, Chairman of Board & CEO
MVMichael Vazquez
Michael VazquezCo-founder & Executive Vice PresidentMichael Vazquez is co-founder and executive vice president of LYNK Pharmaceuticals, which develops small molecule pharmaceutical products for oncology and autoimmune indications.
JWJun Wang
Jun WangCo-founder & CSOJun Wang is co-founder and chief scientific officer of LYNK Pharmaceuticals, which develops treatments for rheumatoid arthritis and ankylosing spondylitis. He has published over 50 peer-reviewed papers and served as an editorial board member and reviewer for journals including Nature, Nature Reviews Drug Discovery, and the Journal of Molecular Biology.
YC
Yan ChenCo-founder & COO

Investors · 3

LAVlisted by LAVHong Kong · $5M – $15M
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred

How we know: the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does LYNK Pharmaceuticals do?
Lynk Pharma develops pharmaceutical products for rheumatoid arthritis and ankylosing spondylitis, with selective licensing arrangements for regional commercialization.
Who founded LYNK Pharmaceuticals?
LYNK Pharmaceuticals was founded by Zhao-Kui (ZK) Wan, Michael Vazquez, Jun Wang, Yan Chen.
Who are LYNK Pharmaceuticals's investors?
LYNK Pharmaceuticals's investors include Decheng Capital, LAV, Lilly Asia Ventures.
Where is LYNK Pharmaceuticals headquartered?
LYNK Pharmaceuticals is headquartered in Hangzhou, CN.